The collapsin response mediator proteins (CRMPs) (also known as TOAD (turned on after division), Ulip (unc-33 like protein) and DRP (dihydropyrimidinase family) are a conserved family of cytosolic phosphoproteins highly expressed in the nervous system (Wang and Strittmatter, 1996) . Even though the CRMPs exhibit more than 60% amino acid identity to the amidohydrolase family, they do not possess enzymatic activity (Wang and Strittmatter, 1997) .
CRMP proteins are also targets of a variety of protein kinases. CRMP-2 and CRMP-4 were identified as brain-specific substrates for glycogen synthase kinase 3 (GSK3) and during growth cone collapse, phosphorylation by Rho-associated kinase inhibits microtubule assembly and Numb-mediated endoyctosis Yoshimura et al., 2005; Cole et al., 2006) . Recently, CRMP-2 was identified as a negative regulator of p53 and it has been suggested to play a role in the regulation of proliferation (Llanos et al., 2006; Tahimic et al., 2006) . Moreover, the CRMPs may contribute to the pathogenesis of specific neurodegenerative disorders (Charrier et al., 2003) .
Presently, we describe the expression analysis of CRMP-4, during early Xenopus embryogenesis. CRMP-4 is expressed in the differentiating primary neurons and later expression is maintained throughout the central nervous system and in the eye. Correspondingly, CRMP-4 is positively regulated by X-ngnr-1 and negatively regulated by the Notch pathway.
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Results and Discussion
Xenopus CRMP-4 was identified in a microarray screen aimed at identifying genes induced in dissociated ectodermal explants by the neuronal determination transcription factor, X-ngnr-1. Comparison of the predicted amino acid sequence revealed Xenopus CRMP-4 is 90% identical to the corresponding human and mouse sequences. Lower identity was observed between Xenopus CRMP-2 (75%) and other mammalian CRMP members (71-74%) (Fig. 1) . The Cdk5 priming and GSK3 phosphorylation sites identified in the mammalian CRMP-2 are conserved (Uchida et al., 2005; Yoshimura et al., 2005) .
The expression of CRMP-4 during early Xenopus embryogenesis was investigated by RT-PCR analysis with RNA isolated from various stages of development ( Fig. 2A) . Zygotic transcripts of CRMP-4 were detected at low levels by the end of gastrulation, increased during neurula stages and were maintained at constant levels throughout tailbud stages and later development.
As shown in Figure 2B and 2C, transcripts are first detected at stage 11.5 by whole mount in situ hybridization, broadly throughout the prospective neural ectoderm. At stage 12.5, CRMP-4 is enriched in the anterior neural plate and two longitudinal stripes flanking the midline (Fig. 2D) . As development proceeds, the posterior expression becomes more prominent and CRMP-4 is strongly detected throughout the territories of primary neurogenesis including the medial, intermediate and lateral stripes, where motor-, inter-and sensory neurons will later differentiate, respectively ( Fig. 2E-G) (Chitnis et al., 1995) . This pattern of expression is similar to that of proneural transcription factors and prefigures that of the neural specific β-tubulin (N-tubulin), which marks 522 1MS_YQGKKNIPRITSDRLLIKGGRIVNDDQSFYADIYMEDGLIKQIGDNLIVPGGVKTIE 1""_""""""""""""""""""""""""""""""""""""""""""""""""""""""""" 1""_""""""""""""""""""""K"""""""""""""""""""""""E"""""""""""" 1MSG""""""""""""""""""""K""""""""H""""""""""""""E"""""""""""" 60ANGKMVIPGGIDVHTHLQMPYRGMTTVDDFFQGTKAALAGGTTMIVDHVIPEPEASLTEA 60""""""""""""""""F""""K"""""""""""""""""""""""I"""V""""S""""" 60"HSR"""""""""""RF"""DQ"""SA""""""""""""""""""I"""V"""GT""LA" 61"H"R""V""""""""CF"K"CN""VSS"""L""""""""""""""I"""V"""GS""LS" 120LEKWREWADGKTCCDYSLHVDITHWSDSVKQEVETLVKQKGVNSFMVYMAYKDMYQMSNT 120Y""""""""""S""""A""""""""N"""""""QN"I"D""""""""""""""L""V""" 120FDQ""""""S"S""""""""""SE"HKGIQE"M"A"""DH"""""L""""F""RF"LTDC 121FDQ""""""A"S"""""""""""E"HKG"QE"M"A"""DH"""""L"""""""Q""LTDS 180ELYEIFTFLGGLGAIAQVHAENGDIIAQEQNRMLELGITGPEGHVLSRPEELEAEAVFRA 180"""""""C""E"""""""""""""""""""T""""M"""""""""""""""""""""""" 180 QI""VLSVIRDI"""""""""""""""E""Q"I"D""""""""""""""""V"""""N"" 181 QI""V"SVIRDI""""E"""""""V""E""F"I""Q"""""""""""""""V"""""N"S 240ITIASQTNCPLYVTKVMSKSSVDLISQARKKGYVVFGEPITASLGTDGTHYWSKNWAKAA 240""""""""""""""""""""AA""""""""""N""""""""""""I"""""""""""""" 240""""N"""""""I""""""""AEV"A""""""T""Y""""""""""""S""""""""""" 241"""SN""""""""""""""""AEV"A""""""A""Y""""""""""""S""""""""""" 300AFVTSPPLSPDPTTPDYINSLLASGDLQVTGSAHATFSTAQKAIGKDNFTLIPEGTNGIE 300""""""""""""""""""""""""""""LS""""C"""""""""""""""A"""""""V" 300""""""""""""""""FL""""SC""""""""""C""N"""""V""""""""""""""T" 301""""""""""""S"""FL""""SC"""""C""""C""N"""""V"""""V""""""""A" 360ERMSVIWDKSVATGKMDENQFVAVTSTNAAKIFNLYPRKGRIAVGSDSDLVIWDPDAVKI 360"""""""""A""""""""""""""""""""""""""""""""S""""""""""""""""" 360"""""""""A"V"""""""""""""""""""V"""""""""""""""A""""""""S""T 361""""IV""RA"V"""""""""""""""""""""""""""""""""""A""""""""NLRT 420VSAKSHHSAAEYNIFEGMELRGAPLVVICQGKIMMEDGTLHATQGTGRFIPCSPFPDYVY 420""""N"Q"""""""""""""""""""""""""""L"""N""V"""A"""""""""S"""" 420I"""T"N"SL"""""""""C""S"""""S""""VL""""""V"E"S""Y""RK""""F"" 421I"""T"N"NV"""""""""C""S"""""S""""VL"E""""""E"S""Y""RK""""""" 480KRIKARTKMAELHAVPRGMYDGPVHDLASTPKAGTPAGSTKGSPTKQ_TA_PVRNLHHSG 480""""""R"""D"""""""""""""F""TT"""G""""""AR""""RP_NP_""""""Q"" 480""""""SRL"""RG""""L"""""CEVSV"""TV"""S"A"T""A""QAP_""""""Q"" 481""""""SRL"""RG""""L"""""CEVSV""""V"""S"A"T""A""_P"Q"I""""Q"" 538FSLIGNQADESGVRSASRRIVAPPGGRSNITSLS 538"""S"T"V""_""""""K"""""""""""""""" 539"""S"A"I"DNIP"RTTQ"""""""""A"""""G 540"""S"A"V"DNIP"RTTQ"""""""""A"""""G terminally differentiated neurons (Oschwald et al., 1991) . Transcripts are still detected broadly throughout the anterior neural plate and in a lateral group of cells associated with the trigeminal ganglia. Neuronal differentiation in the anterior neural plate is delayed until tadpole stages, thus in contrast to CRMP-4, known proneural genes are absent from this territory (Papalopulu and Kintner, 1996) . This restricted expression in the posterior neural plate contrasts the panneural expression of Xenopus CRMP-2 (Kamata et al., 1998) . During neurula and early tailbud stages, CRMP-4 transcripts are found throughout the central nervous system including the developing brain and neural tube, as well as the eye (Fig 2I-K) . As shown by the transversal section, transcripts of CRMP-4 are present primarily in the subventricular and outer marginal layers of the neural tube ( Fig  2L) , where cells that initiate differentiation and post-mitotic cells are localized, respectively. Additionally, in the anterior ventrolateral region of the embryo, a scattered ring of cells expresses CMPR-4. A transversal section demonstrates that these are isolated cells lying immediately below the ectoderm (Fig. 2M) . These CRMP-4 expressing cells are maintained through tailbud stages but disappear at tadpole stages (compare Fig. 2K and  N) . This punctuate pattern is similar to that of Xphox2A and XHand2 and has been suggested to be progenitors of smooth muscle cells or pericytes of the forming vasculature (Smith et al., 2000; Talikka et al., 2004) . Interestingly, we have also observed a similar punctuate expression by other proneural genes such as X-MyT1 (data not shown) and N-tubulin (Fig 2P) suggesting they are neuronal cells. At tadpole stages (Fig. 2N) , CRMP-4 expression is maintained in the CNS, the eye, as well as in the cranial ganglion IX (glossopharyngeal) and X (vagus ganglion) cells. Consistent with the exclusion of CRMP-4 from the proliferating cells of the neural tube, staining in the eye is found in the central and marginal zones of the retina and is absent from the ciliary marginal zone where proliferating retinoblasts are found (Fig. 2O) . The regulation of CRMP-4 was studied in ectodermal explants (animal caps) from blastula stage embryos; these explants are normally fated to become epidermal tissue, but can be converted to derivatives of all three germ layers. The animal blastomeres of two-cell stage Xenopus embryos were injected bilaterally with mRNA encoding putative regulators and animal caps were dissected at blastula stage. Total RNA was isolated at stage 14 and analyzed by RT-PCR. As shown in Fig. 3A , animal caps neuralized with the BMP inhibitor Noggin exhibited strong induction of NCAM as compared with uninjected animal caps, but no influence on CRMP-4 expression was observed. This is in contrast to the regulation of the closely related CRMP-2, which is activated by Noggin ( Figure 3A and Kamata et al., 1998) . The neuronal determination factor X-ngnr-1 robustly induced the activation of both CRMP-4 and CRMP-2. The positive regulation of CRMP-2 by X-ngnr-1 is similar to the activation of other panneural genes such as Nrp-1 and NCAM (Klisch et al., 2006) .
CRMP-4 in developing Xenopus
The regulation of CRMP-4 was also investigated in whole embryos. mRNAs encoding putative regulatory factors were injected into one blastomere of two-cell stage embryos together with LacZ mRNA to localize the distribution of the injected mRNA. Consistent with the results from the animal cap assay, in whole embryos, X-ngnr-1 ectopically activated CRMP-4 within the neural and non-neural ectoderm (100%, n=50; Fig.  3B ). In addition to its proneural activity, X-ngnr-1 activates the Notch pathway in the neighboring cell, thereby restricting the number of cells that undergo neuronal differentiation. Overexpression of the intracellular domain of Notch1 receptor (Notch-ICD), which functions as a constitutively active form of Notch Coffman et al., 1993) , inhibits CRMP-4 expression on the injected side (97%, n=57; Fig. 3B ).
Taken together, the temporal expression pattern observed in the territories of primary neurogenesis, as well as the regulation of CRMP-4 by Notch signaling and X-ngnr-1, support an early role for CRMP-4 in neuronal precursor cells as they initiate differentiation during primary neurogenesis. Both expression and regulation ofCRMP-4 differ from that of CRMP-2, which is induced by the events of neural induction. It will be of interest to elucidate the function of CRMP-4 during the differentiation of primary neurons in Xenopus, as the CRMP family has primarily been characterized during neuronal maturation in mammalian systems.
Experimental Procedures
Xenopus CRMP-4 CRMP-4 was identified in a Xenopus cDNA library obtained from the German Resource Center for Genome Research (IMAGE ID: 4408246, Accession number BC082618). The Xenopus CRMP-4 cDNA clone contained 1909 bp insert comprising 146 bp of 5'-UTR, 1713 bp of coding sequence and 50 bp of 3'-UTR in pCMVSport6.
Xenopus embryo collection and whole mount in situ hybridization
Xenopus laevis embryos were obtained by HCG induced egglaying, dejellied in 2% cysteine pH 8.0, washed and cultured in 0.1X MBS. Embryos were fixed in MEMFA at the desired stage according to Nieuwkoop and Faber (1967) . The spatial expression patterns were determined by whole mount in situ hybridization (Harland, 1991 ) using a DIG labelled antisense probe. XCRMP-4pCMVSport6 was linearized with EcoRI and transcribed with T7 polymerase. Embryos were embedded in gelatine and 30 µm sections were prepared using a vibratome.
Microinjection of embryos
Capped mRNA for microinjections were prepared by in vitro transcription (mMessage-mMachine™ Ambion) and purified over an RNeasy column (Qiagen). Embryos were injected in one or both blastomere of the two-cell stage with the indicated amount of RNA: 50 pg Noggin (Smith et al., 1993) , 50 pg Notch-ICD (Coffman et al., 1993) , 25 pg Xngnr-1 (Ma et al., 1996) . As a lineage tracer, 50 pg nuclear lacZ mRNA was coinjected (Chitnis et al., 1995) .
Animal cap assay and RT-PCR
Two-cell stage embryos were injected bilaterally, animal caps dissected from stage 8-9 embryos and cultured until sibling controls reached stage 14. Total RNA was extracted from the various embryonic stages or animal caps (Qiagen RNeasy Kit) and cDNA prepared using random hexamer primers and MuLV reverse transcriptase (PerkinElmer). PCR was performed with Taq polymerase using the following gene specific oligonucleotide primer pairs: Histone H4 (26 cycles) forward: 5´-CGGGATAACATTCAGGGTATCACT-3ŕ everse: 5´-ATCCATGGCGGTAACTGTCTTCCT-3Ń CAM (32 cycles) forward: 5´-CACAGTTCCACCAAATGC-3ŕ everse: 5´-GGAATCAAGCGGT5ACAGA-3´ (Hemmati-Brivanlou and Melton, 1994) . N-tubulin (28 cycles) forward: 5´-ACACGGCATTGATCCTACAG-3ŕ everse: 5´-AGCTCCTTCGGTGTAATGAC-3´ (Good et al., 1989) . CRMP-2 (30 cycles) forward: 5´-GGAGAACATGGTTCACACTA-3ŕ everse: 5´-TGCAGCATTTGTACTGGTGAC-3' (Kamata et al., 1998) .
CRMP-4 (28 cycles)
forward: 5´-GGAACATTGGCGAGAGAGAAC-3ŕ everse: 5´-GTTGTCTCCAATCTGCTTGAT-3´.
